<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03319173</url>
  </required_header>
  <id_info>
    <org_study_id>Bristlecone-001</org_study_id>
    <nct_id>NCT03319173</nct_id>
  </id_info>
  <brief_title>Dietary Ketosis: Fatty Acids Activate AMPK Energy Circuits Modulating Global Methylation</brief_title>
  <official_title>Dietary Ketosis a Metabolic Sister to Calorie Restriction (CR): Fatty Acids Activate AMPK Energy Circuits Modulating Global Methylation Via the SAM/SAH Axis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bristlecone Health, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Minnesota</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Bristlecone Health, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study explores whether selective memory complaints (SMC), mild cognitive impairment (MCI)
      and the comorbidity of Metabolic Syndrome symptomatic of peripheral and cerebral
      hypo-metabolism with corresponding epigenetic shifts in global DNA (deoxyribonucleic acid)
      methylation (away from nutrient availability and toward biosynthesis) are initiated by
      chronic metabolic inflexibility, over-activation of the mTOR (mammalian target of rapamycin)
      pathway, and the deregulation of neural oxidative phosphorylation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Nutritional epigenetics denotes gene-diet interactions and highlights the modulatory role of
      cellular energy status in aging and age-related diseases like cancer, cardiovascular disease
      (CVD), diabetes and neurodegeneration. Nutrients are epigenetic modifiers; macro and
      micronutrients regulate the placement and distribution of DNA histone modifiers
      distinguishing phenotype from genotype. Cellular energy status (AMP/ATP) modulates the
      regulatory mechanics of DNA methylation via the SAM (S-adenosylmethionine) methlytransferase
      and the SAH (S-adenosyl homocysteine) methyltransferase inhibitor index. Whole blood
      histamine and homocysteine levels provide additional information on the status of
      methylation. Hyperinsulinemia and cellular insulin resistance dysregulate nutrient sensing
      pathways; perpetual fed-state signaling exacerbates systemic metabolic inflexibility. Chronic
      elevations in insulin with long-standing impairments in glucose delivery are associated with
      profound changes in epigenetic expression consequent of hyper-activation of mTOR and
      inhibition of AMPK kinase pathways. Dietary ketosis is known to govern adaptive mitonuclear
      energy availability by increasing cellular reduction potential via &gt;AMP/ATP ratio. AMPK
      activation adapts rRNA synthesis away from fed-state growth/storage toward energy
      production/release, common to fasted-states. Research suggests that induced and controlled
      dietary ketogenesis, a fasting mimetic, transcriptionally modifies gene expression thereby
      attenuating metabolic diseases.

      The study will explore whether early stage memory loss (SMC &amp; MCI) and comorbidity of
      Metabolic Syndrome are symptomatic of peripheral and cerebral hypo-metabolism resultant of
      sustained cellular insulin resistance. The investigators will attempt to show that consequent
      to systemic hyperinsulinemia, mitonuclear crosstalk dysregulates the energy sensing kinases,
      mTOR/AMPK, thereby modifying the intra/extracellular nutrient signaling pathways. The
      suppression of AMPK, coupled with chronic fed-state signaling, adapts rRNA synthesis away
      from nutrient availability toward ATP consuming processes. Increased biosynthesis of
      proteins, lipids and cholesterol with concurrent inhibition of fat oxidation, energy
      cofactors (NAD+, SAHH) and programmed apoptosis results in the epigenetic drift of
      methylation toward global gene activation with region-specific silencing of key
      regulatory/longevity genes, SIRTs (sirtuins), FOX03 and Nrf2. This global shift in energy is
      marked by suppression of the SAM/SAH methylation index and correlative jumps in whole blood
      histamine and/or homocysteine. The study explores whether the aforementioned shift in
      nutrient sensing pathways modulates metabolic inflexibility via energy shunts toward
      cytosolic, substrate level phosphorylation via activation of PDK (pyruvate dehydrogenase
      kinase). An insulin resistant energy surplus (&lt;AMP/ATP) fosters low cellular reduction
      potential, which triggers mitonuclear crosstalk inhibiting oxidative ATP via PDC (pyruvate
      dehydrogenase complex), the regulatory gateway between anaerobic glycolysis and oxidative
      mitochondrial respiration. The study will attempt to show that induced and controlled dietary
      ketosis initiates the spontaneous/favorable release of energy ( &gt;AMP/ATP), activating the
      AMPK circuitry thereby inhibiting the synthesis/storage of protein, cholesterol and lipids.
      Thus, a shift in cellular energy from low reduction potential (ATP/NADH) to high reduction
      potential (AMP/NAD+) attenuates methylation drift evidenced by marked reductions in
      biosynthesis: fasting lipid profile (TRI., VLDL, LDL, HDL), LP-IR score (particle
      concentration/size), HgA1c, fasting insulin, HOMA-IR and epigenetic modification of DNA
      measured by improved methylation index (&gt;SAM/SAH) with correlating reductions in whole blood
      histamine and/or homocysteine. The resultant change in cerebral glucose metabolism and
      correlative improvement in SMC/MCI will be assessed by valid clinical measures of cognition:
      Montreal Cognitive Assessment (MoCA), Brief Visual Memory Test-Revised (BVMT-R) and Rey
      Auditory Verbal Learning Task (RAVLT) administered at baseline and weeks 2/4/6/8/10/12.

      Research Question: Are selective memory complaints (SMC), mild cognitive impairments (MCI)
      and comorbid Metabolic Syndrome symptomatic of peripheral/cerebral insulin resistance with a
      resultant epigenetic drift in methylation away from energy production toward anabolic
      synthesis/storage, initiated and sustained by metabolic inflexibility, aerobic glycolysis and
      PDK inhibition of oxidative phosphorylation?
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 15, 2017</start_date>
  <completion_date type="Actual">September 30, 2018</completion_date>
  <primary_completion_date type="Actual">September 30, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>To assess differences between the control and experimental groups, a mixed model will be fit for each variable separately using both baseline (week 0) and post program (week 12) values for each subject. Models will include week, group, and their interaction as fixed effects, gender as a covariate, and subject as a random effect. To assess significant differences, we will use the difference at week 12 adjusted for the baseline difference, and will report p-values, least squares means, and 95% confidence intervals. Further analysis of treatment effects over time will be examined by comparing the within-group differences over time.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>MoCA (Montreal Cognitive Assessment)</measure>
    <time_frame>12 weeks</time_frame>
    <description>Measures changes in cognitive function over time. Score: 30 points (maximum), 0 points (minimum). Score &gt;25 = normal cognitive function. Score 17-25 = mild cognitive impairment (MCI). Score &lt;17 = increased likelihood of Alzheimer's Disease or dementia.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>NMR Lipoprofile Particle Size - Small LDL-P</measure>
    <time_frame>12 weeks</time_frame>
    <description>Assessment of changes in Small LDL-P (total small Pattern B)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>NMR Lipoprofile Particle Size - LP-IR Score (Lipoprotein Insulin Resistance) Ideal Range: &lt;45</measure>
    <time_frame>12 weeks</time_frame>
    <description>Lipoprotein insulin resistance (LP-IR) is an aggregate score of the 6 lipoprotein parameters range from 0 to 100, with higher scores indicating greater insulin resistance (IR).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fasting Triglycerides</measure>
    <time_frame>12 weeks</time_frame>
    <description>Assessment of changes in fasting triglycerides over time. Ranges: &lt; 150 mg/dL</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Triglyceride/HDL Ratio</measure>
    <time_frame>12 weeks</time_frame>
    <description>Assessment of changes in Triglyceride/HDL ratio over time.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fasting Insulin</measure>
    <time_frame>12-weeks</time_frame>
    <description>Assessment of changes in fasting insulin over time. Ranges: &lt; 2.6-11.1 mU/L</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Fasting Glucose</measure>
    <time_frame>12-weeks</time_frame>
    <description>Assessment of changes in fasting glucose over time. Ranges: &lt; 74-100 mg/dL</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HOMA-IR</measure>
    <time_frame>12-weeks</time_frame>
    <description>Assessment of changes in HOMA-IR (Homeostatic Model Assessment of Insulin Resistance) over time. Ranges: &lt; 1.0</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HgA1c</measure>
    <time_frame>12-weeks</time_frame>
    <description>Assessment of changes in HgA1c (Hemoglobin A1c) over time.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Weight</measure>
    <time_frame>12-weeks</time_frame>
    <description>Assessment of changes in weight over time as measured in pounds.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body Fat Mass (BFM)</measure>
    <time_frame>12-weeks</time_frame>
    <description>Assessment of changes in body fat mass over time as measured in pounds.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>VLDL</measure>
    <time_frame>12-weeks</time_frame>
    <description>Assessment of changes in VLDL (very low density lipoprotein carrier) over time. Ranges: &lt; 5-40 mg/dL</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SAM/SAH Ratio (S-adenosylmethionine/S-adenosylhomocysteine)</measure>
    <time_frame>12-weeks</time_frame>
    <description>Assessment of changes in SAM/SAH (S-adenosylmethionine/S-adenosylhomocysteine) ratio Range: &gt;4.0</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SAM (S-adenosylmethionine)</measure>
    <time_frame>12-weeks</time_frame>
    <description>Assessment of changes in SAM (S-adenosylmethionine)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SAH (S-adenosylhomocysteine)</measure>
    <time_frame>12-weeks</time_frame>
    <description>Assessment of changes in SAH (S-adenosylhomocysteine) Range: 10-22 nmol/L</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adenosine</measure>
    <time_frame>12-weeks</time_frame>
    <description>Assessment of changes in Adenosine Range: 20-80 nmol/L</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">98</enrollment>
  <condition>Mild Cognitive Impairment</condition>
  <condition>Metabolic Syndrome</condition>
  <arm_group>
    <arm_group_label>Experimental group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dietary interventions for subjects in the experimental group include clinically regulated meal plans designed to facilitate prolonged benign dietary ketosis (BDK) in order to regulate glucose with restored insulin sensitivity focused at reversing the impaired capacity to switch between fat and carbohydrate oxidation. Subjects will consume 3 meals per day with the following approximate macronutrient breakdown per meal: 65% fat, 25% protein, 10% carbohydrate.
Both groups will play the Advanced PEAK brain training games on iPhone, iPad or Android devices for 75 minutes per week.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Dietary interventions for subjects in the control group include the subjects' current dietary protocol (Standard American Diet-SAD). Subjects will consume 4-6 small meals per day with the following approximate macronutrient breakdown per meal: 50% carbohydrate, 35% protein, 15% fat.
Both groups will play the Advanced PEAK brain training games on iPhone, iPad or Android devices for 75 minutes per week.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Dietary intervention</intervention_name>
    <description>Subjects in the experimental group will receive clinically regulated meal plans designed to facilitate prolonged benign dietary ketosis (BDK) in order to regulate glucose with restored insulin sensitivity focused at reversing the impaired capacity to switch between fat and carbohydrate oxidation.
Subjects in the control group will follow the their current dietary protocol (Standard American Diet-SAD).</description>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_label>Experimental group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male or Female (age 35-80)

          -  Previously diagnosed with MetS and/or T2DM as measured by possessing at least two of
             the following physiological measures: type 2 diabetes, BMI &gt; 30, HgA1c &gt; 5.7%,
             waist/height ratio &gt; .6, fasting glucose &gt; 125 mg/dL

          -  Subjective Memory Complaints (SCM) - Subjects score &gt; 3 'yes' answers on the
             Subjective Memory Complaints Questionnaire

          -  Previously diagnosed with Mild Cognitive Impairment (MCI)

        Exclusion Criteria:

          -  Previously diagnosed with Alzheimer's disease (AD), dementia or Parkinson's disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kelly J Gibas, Doctorate</last_name>
    <role>Principal Investigator</role>
    <affiliation>Bristlecone Health, Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Bristlecone Health, Inc.</name>
      <address>
        <city>Maple Grove</city>
        <state>Minnesota</state>
        <zip>55311</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>October 14, 2017</study_first_submitted>
  <study_first_submitted_qc>October 19, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 24, 2017</study_first_posted>
  <results_first_submitted>February 7, 2019</results_first_submitted>
  <results_first_submitted_qc>November 7, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">November 12, 2019</results_first_posted>
  <last_update_submitted>November 7, 2019</last_update_submitted>
  <last_update_submitted_qc>November 7, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 12, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Mild Cognitive Impairment</keyword>
  <keyword>AMPK activation</keyword>
  <keyword>DNA global hypo-methylation</keyword>
  <keyword>Metabolic Syndrome</keyword>
  <keyword>Ketogenic diet</keyword>
  <keyword>SAM/SAH Index</keyword>
  <keyword>S-adenosylmethionine (SAM)</keyword>
  <keyword>S-adenosylhomocysteine (SAH)</keyword>
  <keyword>Region-Specific hyper-methylation</keyword>
  <keyword>mTOR kinase pathway</keyword>
  <keyword>AMP/ATP ratio</keyword>
  <keyword>Low Reduction Potential</keyword>
  <keyword>High Reduction Potential</keyword>
  <keyword>Delta G</keyword>
  <keyword>Exergonic</keyword>
  <keyword>Endergonic</keyword>
  <keyword>Epigenetic Histone Modification</keyword>
  <keyword>Montreal Cognitive Assessment (MoCA)</keyword>
  <keyword>Brief Visual Memory Test-Revised (BVMT-R)</keyword>
  <keyword>Rey Auditory Verbal Learning Task (RAVLT)</keyword>
  <keyword>HOMA-IR</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Metabolic Syndrome</mesh_term>
    <mesh_term>Cognitive Dysfunction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>September 15, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/73/NCT03319173/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>January 15, 2019</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/73/NCT03319173/SAP_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Experimental Group</title>
          <description>Dietary interventions for subjects in the experimental group include clinically regulated meal plans designed to facilitate prolonged benign dietary ketosis (BDK) in order to regulate glucose with restored insulin sensitivity focused at reversing the impaired capacity to switch between fat and carbohydrate oxidation. Subjects will consume 3 meals per day with the following approximate macronutrient breakdown per meal: 65% fat, 25% protein, 10% carbohydrate.
Both groups will play the Advanced PEAK brain training games on mobile devices for 75 minutes per week.
Dietary intervention:Subjects in the experimental group will receive clinically regulated meal plans designed to facilitate prolonged benign dietary ketosis (BDK) in order to regulate glucose with restored insulin sensitivity focused at reversing the impaired capacity to switch between fat and carbohydrate oxidation.
Subjects in the control group will follow the their current dietary protocol (Standard American Diet-SAD).</description>
        </group>
        <group group_id="P2">
          <title>Control Group</title>
          <description>Dietary interventions for subjects in the control group include the subjects' current dietary protocol (Standard American Diet-SAD). Subjects will consume 4-6 small meals per day with the following approximate macronutrient breakdown per meal: 50% carbohydrate, 35% protein, 15% fat.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="48"/>
                <participants group_id="P2" count="50"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="48"/>
                <participants group_id="P2" count="50"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Experimental Group</title>
          <description>Dietary interventions for subjects in the experimental group include clinically regulated meal plans designed to facilitate prolonged benign dietary ketosis (BDK) in order to regulate glucose with restored insulin sensitivity focused at reversing the impaired capacity to switch between fat and carbohydrate oxidation. Subjects will consume 3 meals per day with the following approximate macronutrient breakdown per meal: 65% fat, 25% protein, 10% carbohydrate.
Both groups will play the Advanced PEAK brain training games on iPhone, iPad or Android devices for 75 minutes per week.
Dietary intervention: Subjects in the experimental group will receive clinically regulated meal plans designed to facilitate prolonged benign dietary ketosis (BDK) in order to regulate glucose with restored insulin sensitivity focused at reversing the impaired capacity to switch between fat and carbohydrate oxidation.</description>
        </group>
        <group group_id="B2">
          <title>Control Group</title>
          <description>Dietary interventions for subjects in the control group include the subjects' current dietary protocol (Standard American Diet-SAD). Subjects will consume 4-6 small meals per day with the following approximate macronutrient breakdown per meal: 50% carbohydrate, 35% protein, 15% fat.
Both groups will play the Advanced PEAK brain training games on iPhone, iPad or Android devices for 75 minutes per week.
Dietary intervention: Subjects in the control group will follow the their current dietary protocol (Standard American Diet-SAD).</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="48"/>
            <count group_id="B2" value="50"/>
            <count group_id="B3" value="98"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="48"/>
                    <count group_id="B2" value="50"/>
                    <count group_id="B3" value="98"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="41"/>
                    <measurement group_id="B2" value="44"/>
                    <measurement group_id="B3" value="85"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="6"/>
                    <measurement group_id="B3" value="13"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="48"/>
                    <count group_id="B2" value="50"/>
                    <count group_id="B3" value="98"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="25"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="50"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                    <measurement group_id="B2" value="25"/>
                    <measurement group_id="B3" value="48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="48"/>
                    <count group_id="B2" value="50"/>
                    <count group_id="B3" value="98"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="48"/>
                    <measurement group_id="B2" value="50"/>
                    <measurement group_id="B3" value="98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>MoCA (Montreal Cognitive Assessment)</title>
          <description>MoCA score ranges:
Normal: &gt;= 26; MCI (mild cognitive impairment): 17-25</description>
          <units>units on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="48"/>
                    <count group_id="B2" value="50"/>
                    <count group_id="B3" value="98"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28.38" lower_limit="27.94" upper_limit="28.81"/>
                    <measurement group_id="B2" value="20.22" lower_limit="19.79" upper_limit="20.64"/>
                    <measurement group_id="B3" value="24.30" lower_limit="23.50" upper_limit="25.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>MoCA (Montreal Cognitive Assessment)</title>
        <description>Measures changes in cognitive function over time. Score: 30 points (maximum), 0 points (minimum). Score &gt;25 = normal cognitive function. Score 17-25 = mild cognitive impairment (MCI). Score &lt;17 = increased likelihood of Alzheimer's Disease or dementia.</description>
        <time_frame>12 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Experimental Group</title>
            <description>MoCA post intervention score</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>MoCA post intervention score</description>
          </group>
        </group_list>
        <measure>
          <title>MoCA (Montreal Cognitive Assessment)</title>
          <description>Measures changes in cognitive function over time. Score: 30 points (maximum), 0 points (minimum). Score &gt;25 = normal cognitive function. Score 17-25 = mild cognitive impairment (MCI). Score &lt;17 = increased likelihood of Alzheimer's Disease or dementia.</description>
          <units>score on a scale</units>
          <param>Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
                <count group_id="O2" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28.38" spread="0.22"/>
                    <measurement group_id="O2" value="20.22" spread="0.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <method>Regression, Linear</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>8.24</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.23</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>7.79</ci_lower_limit>
            <ci_upper_limit>8.7</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>NMR Lipoprofile Particle Size - Small LDL-P</title>
        <description>Assessment of changes in Small LDL-P (total small Pattern B)</description>
        <time_frame>12 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Experimental Group</title>
            <description>Dietary interventions for subjects in the experimental group include clinically regulated meal plans designed to facilitate prolonged benign dietary ketosis (BDK) in order to regulate glucose with restored insulin sensitivity focused at reversing the impaired capacity to switch between fat and carbohydrate oxidation. Subjects will consume 3 meals per day with the following approximate macronutrient breakdown per meal: 65% fat, 25% protein, 10% carbohydrate.</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>Dietary interventions for subjects in the control group include the subjects' current dietary protocol (Standard American Diet-SAD). Subjects will consume 4-6 small meals per day with the following approximate macronutrient breakdown per meal: 50% carbohydrate, 35% protein, 15% fat.</description>
          </group>
        </group_list>
        <measure>
          <title>NMR Lipoprofile Particle Size - Small LDL-P</title>
          <description>Assessment of changes in Small LDL-P (total small Pattern B)</description>
          <units>nmol/L</units>
          <param>Geometric Least Squares Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
                <count group_id="O2" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="276.24" spread="29.25"/>
                    <measurement group_id="O2" value="588.08" spread="61.02"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <method>Regression, Linear</method>
            <param_type>Estimate</param_type>
            <param_value>0.35</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.02</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.31</ci_lower_limit>
            <ci_upper_limit>0.39</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>NMR Lipoprofile Particle Size - LP-IR Score (Lipoprotein Insulin Resistance) Ideal Range: &lt;45</title>
        <description>Lipoprotein insulin resistance (LP-IR) is an aggregate score of the 6 lipoprotein parameters range from 0 to 100, with higher scores indicating greater insulin resistance (IR).</description>
        <time_frame>12 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Experimental Group</title>
            <description>Dietary interventions for subjects in the experimental group include clinically regulated meal plans designed to facilitate prolonged benign dietary ketosis (BDK) in order to regulate glucose with restored insulin sensitivity focused at reversing the impaired capacity to switch between fat and carbohydrate oxidation. Subjects will consume 3 meals per day with the following approximate macronutrient breakdown per meal: 65% fat, 25% protein, 10% carbohydrate.
Both groups will play the Advanced PEAK brain training games on iPhone, iPad or Android devices for 75 minutes per week.
Dietary intervention: Subjects in the experimental group will receive clinically regulated meal plans designed to facilitate prolonged benign dietary ketosis (BDK) in order to regulate glucose with restored insulin sensitivity focused at reversing the impaired capacity to switch between fat and carbohydrate oxidation.</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>Dietary interventions for subjects in the control group include the subjects' current dietary protocol (Standard American Diet-SAD). Subjects will consume 4-6 small meals per day with the following approximate macronutrient breakdown per meal: 50% carbohydrate, 35% protein, 15% fat.
Both groups will play the Advanced PEAK brain training games on iPhone, iPad or Android devices for 75 minutes per week.
Dietary intervention: Subjects in the control group will follow the their current dietary protocol (Standard American Diet-SAD).</description>
          </group>
        </group_list>
        <measure>
          <title>NMR Lipoprofile Particle Size - LP-IR Score (Lipoprotein Insulin Resistance) Ideal Range: &lt;45</title>
          <description>Lipoprotein insulin resistance (LP-IR) is an aggregate score of the 6 lipoprotein parameters range from 0 to 100, with higher scores indicating greater insulin resistance (IR).</description>
          <units>score on a scale</units>
          <param>Geometric Least Squares Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
                <count group_id="O2" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="32.13" lower_limit="28.87" upper_limit="35.76"/>
                    <measurement group_id="O2" value="50.66" lower_limit="45.62" upper_limit="56.26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <method>Regression, Linear</method>
            <param_type>Estimate</param_type>
            <param_value>0.46</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.03</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.41</ci_lower_limit>
            <ci_upper_limit>0.52</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Fasting Triglycerides</title>
        <description>Assessment of changes in fasting triglycerides over time. Ranges: &lt; 150 mg/dL</description>
        <time_frame>12 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Experimental Group</title>
            <description>Dietary interventions for subjects in the experimental group include clinically regulated meal plans designed to facilitate prolonged benign dietary ketosis (BDK) in order to regulate glucose with restored insulin sensitivity focused at reversing the impaired capacity to switch between fat and carbohydrate oxidation. Subjects will consume 3 meals per day with the following approximate macronutrient breakdown per meal: 65% fat, 25% protein, 10% carbohydrate.
Both groups will play the Advanced PEAK brain training games on iPhone, iPad or Android devices for 75 minutes per week.
Dietary intervention: Subjects in the experimental group will receive clinically regulated meal plans designed to facilitate prolonged benign dietary ketosis (BDK) in order to regulate glucose with restored insulin sensitivity focused at reversing the impaired capacity to switch between fat and carbohydrate oxidation.</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>Dietary interventions for subjects in the control group include the subjects' current dietary protocol (Standard American Diet-SAD). Subjects will consume 4-6 small meals per day with the following approximate macronutrient breakdown per meal: 50% carbohydrate, 35% protein, 15% fat.
Both groups will play the Advanced PEAK brain training games on iPhone, iPad or Android devices for 75 minutes per week.
Dietary intervention: Subjects in the control group will follow the their current dietary protocol (Standard American Diet-SAD).</description>
          </group>
        </group_list>
        <measure>
          <title>Fasting Triglycerides</title>
          <description>Assessment of changes in fasting triglycerides over time. Ranges: &lt; 150 mg/dL</description>
          <units>mg/dL</units>
          <param>Geometric Least Squares Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
                <count group_id="O2" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="87.23" lower_limit="76.58" upper_limit="99.35"/>
                    <measurement group_id="O2" value="131.73" lower_limit="115.96" upper_limit="149.64"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <method>Regression, Linear</method>
            <param_type>Estimate</param_type>
            <param_value>0.514</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.02</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.47</ci_lower_limit>
            <ci_upper_limit>0.56</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Triglyceride/HDL Ratio</title>
        <description>Assessment of changes in Triglyceride/HDL ratio over time.</description>
        <time_frame>12 weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Experimental Group</title>
            <description>Dietary interventions for subjects in the experimental group include clinically regulated meal plans designed to facilitate prolonged benign dietary ketosis (BDK) in order to regulate glucose with restored insulin sensitivity focused at reversing the impaired capacity to switch between fat and carbohydrate oxidation. Subjects will consume 3 meals per day with the following approximate macronutrient breakdown per meal: 65% fat, 25% protein, 10% carbohydrate.
Both groups will play the Advanced PEAK brain training games on iPhone, iPad or Android devices for 75 minutes per week.
Dietary intervention: Subjects in the experimental group will receive clinically regulated meal plans designed to facilitate prolonged benign dietary ketosis (BDK) in order to regulate glucose with restored insulin sensitivity focused at reversing the impaired capacity to switch between fat and carbohydrate oxidation.</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>Dietary interventions for subjects in the control group include the subjects' current dietary protocol (Standard American Diet-SAD). Subjects will consume 4-6 small meals per day with the following approximate macronutrient breakdown per meal: 50% carbohydrate, 35% protein, 15% fat.
Both groups will play the Advanced PEAK brain training games on iPhone, iPad or Android devices for 75 minutes per week.
Dietary intervention: Subjects in the control group will follow the their current dietary protocol (Standard American Diet-SAD).</description>
          </group>
        </group_list>
        <measure>
          <title>Triglyceride/HDL Ratio</title>
          <description>Assessment of changes in Triglyceride/HDL ratio over time.</description>
          <units>ratio</units>
          <param>Geometric Least Squares Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
                <count group_id="O2" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.67" lower_limit="1.41" upper_limit="1.99"/>
                    <measurement group_id="O2" value="2.69" lower_limit="2.28" upper_limit="3.19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <method>Regression, Linear</method>
            <param_type>Estimate</param_type>
            <param_value>0.44</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.02</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.40</ci_lower_limit>
            <ci_upper_limit>0.49</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Fasting Insulin</title>
        <description>Assessment of changes in fasting insulin over time. Ranges: &lt; 2.6-11.1 mU/L</description>
        <time_frame>12-weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Experimental Group</title>
            <description>Dietary interventions for subjects in the experimental group include clinically regulated meal plans designed to facilitate prolonged benign dietary ketosis (BDK) in order to regulate glucose with restored insulin sensitivity focused at reversing the impaired capacity to switch between fat and carbohydrate oxidation. Subjects will consume 3 meals per day with the following approximate macronutrient breakdown per meal: 65% fat, 25% protein, 10% carbohydrate.
Both groups will play the Advanced PEAK brain training games on iPhone, iPad or Android devices for 75 minutes per week.
Dietary intervention: Subjects in the experimental group will receive clinically regulated meal plans designed to facilitate prolonged benign dietary ketosis (BDK) in order to regulate glucose with restored insulin sensitivity focused at reversing the impaired capacity to switch between fat and carbohydrate oxidation.</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>Dietary interventions for subjects in the control group include the subjects' current dietary protocol (Standard American Diet-SAD). Subjects will consume 4-6 small meals per day with the following approximate macronutrient breakdown per meal: 50% carbohydrate, 35% protein, 15% fat.
Both groups will play the Advanced PEAK brain training games on iPhone, iPad or Android devices for 75 minutes per week.
Dietary intervention: Subjects in the control group will follow the their current dietary protocol (Standard American Diet-SAD).</description>
          </group>
        </group_list>
        <measure>
          <title>Fasting Insulin</title>
          <description>Assessment of changes in fasting insulin over time. Ranges: &lt; 2.6-11.1 mU/L</description>
          <units>mU/L</units>
          <param>Geometric Least Squares Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
                <count group_id="O2" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7.32" lower_limit="6.37" upper_limit="8.42"/>
                    <measurement group_id="O2" value="11.25" lower_limit="9.81" upper_limit="12.91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <method>Estimate</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>0.44</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.02</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.40</ci_lower_limit>
            <ci_upper_limit>0.49</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Fasting Glucose</title>
        <description>Assessment of changes in fasting glucose over time. Ranges: &lt; 74-100 mg/dL</description>
        <time_frame>12-weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Experimental Group</title>
            <description>Dietary interventions for subjects in the experimental group include clinically regulated meal plans designed to facilitate prolonged benign dietary ketosis (BDK) in order to regulate glucose with restored insulin sensitivity focused at reversing the impaired capacity to switch between fat and carbohydrate oxidation. Subjects will consume 3 meals per day with the following approximate macronutrient breakdown per meal: 65% fat, 25% protein, 10% carbohydrate.
Both groups will play the Advanced PEAK brain training games on iPhone, iPad or Android devices for 75 minutes per week.
Dietary intervention: Subjects in the experimental group will receive clinically regulated meal plans designed to facilitate prolonged benign dietary ketosis (BDK) in order to regulate glucose with restored insulin sensitivity focused at reversing the impaired capacity to switch between fat and carbohydrate oxidation.</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>Dietary interventions for subjects in the control group include the subjects' current dietary protocol (Standard American Diet-SAD). Subjects will consume 4-6 small meals per day with the following approximate macronutrient breakdown per meal: 50% carbohydrate, 35% protein, 15% fat.
Both groups will play the Advanced PEAK brain training games on iPhone, iPad or Android devices for 75 minutes per week.
Dietary intervention: Subjects in the control group will follow the their current dietary protocol (Standard American Diet-SAD).</description>
          </group>
        </group_list>
        <measure>
          <title>Fasting Glucose</title>
          <description>Assessment of changes in fasting glucose over time. Ranges: &lt; 74-100 mg/dL</description>
          <units>mg/dL</units>
          <param>Geometric Least Squares Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
                <count group_id="O2" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="85.9" lower_limit="82.64" upper_limit="89.30"/>
                    <measurement group_id="O2" value="109.61" lower_limit="105.52" upper_limit="113.85"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <method>Regression, Linear</method>
            <param_type>Estimate</param_type>
            <param_value>0.75</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.01</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.72</ci_lower_limit>
            <ci_upper_limit>0.78</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>HOMA-IR</title>
        <description>Assessment of changes in HOMA-IR (Homeostatic Model Assessment of Insulin Resistance) over time. Ranges: &lt; 1.0</description>
        <time_frame>12-weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Experimental Group</title>
            <description>Dietary interventions for subjects in the experimental group include clinically regulated meal plans designed to facilitate prolonged benign dietary ketosis (BDK) in order to regulate glucose with restored insulin sensitivity focused at reversing the impaired capacity to switch between fat and carbohydrate oxidation. Subjects will consume 3 meals per day with the following approximate macronutrient breakdown per meal: 65% fat, 25% protein, 10% carbohydrate.
Both groups will play the Advanced PEAK brain training games on iPhone, iPad or Android devices for 75 minutes per week.
Dietary intervention: Subjects in the experimental group will receive clinically regulated meal plans designed to facilitate prolonged benign dietary ketosis (BDK) in order to regulate glucose with restored insulin sensitivity focused at reversing the impaired capacity to switch between fat and carbohydrate oxidation.</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>Dietary interventions for subjects in the control group include the subjects' current dietary protocol (Standard American Diet-SAD). Subjects will consume 4-6 small meals per day with the following approximate macronutrient breakdown per meal: 50% carbohydrate, 35% protein, 15% fat.
Both groups will play the Advanced PEAK brain training games on iPhone, iPad or Android devices for 75 minutes per week.
Dietary intervention: Subjects in the control group will follow the their current dietary protocol (Standard American Diet-SAD).</description>
          </group>
        </group_list>
        <measure>
          <title>HOMA-IR</title>
          <description>Assessment of changes in HOMA-IR (Homeostatic Model Assessment of Insulin Resistance) over time. Ranges: &lt; 1.0</description>
          <units>units on a scale</units>
          <param>Geometric Least Squares Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
                <count group_id="O2" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.55" lower_limit="1.32" upper_limit="1.83"/>
                    <measurement group_id="O2" value="3.05" lower_limit="2.60" upper_limit="3.57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <method>Estimate</method>
            <param_type>Mean Difference (Final Values)</param_type>
            <param_value>0.33</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.02</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.30</ci_lower_limit>
            <ci_upper_limit>0.37</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>HgA1c</title>
        <description>Assessment of changes in HgA1c (Hemoglobin A1c) over time.</description>
        <time_frame>12-weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Experimental Group</title>
            <description>Dietary interventions for subjects in the experimental group include clinically regulated meal plans designed to facilitate prolonged benign dietary ketosis (BDK) in order to regulate glucose with restored insulin sensitivity focused at reversing the impaired capacity to switch between fat and carbohydrate oxidation. Subjects will consume 3 meals per day with the following approximate macronutrient breakdown per meal: 65% fat, 25% protein, 10% carbohydrate.
Both groups will play the Advanced PEAK brain training games on iPhone, iPad or Android devices for 75 minutes per week.
Dietary intervention: Subjects in the experimental group will receive clinically regulated meal plans designed to facilitate prolonged benign dietary ketosis (BDK) in order to regulate glucose with restored insulin sensitivity focused at reversing the impaired capacity to switch between fat and carbohydrate oxidation.</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>Dietary interventions for subjects in the control group include the subjects' current dietary protocol (Standard American Diet-SAD). Subjects will consume 4-6 small meals per day with the following approximate macronutrient breakdown per meal: 50% carbohydrate, 35% protein, 15% fat.
Both groups will play the Advanced PEAK brain training games on iPhone, iPad or Android devices for 75 minutes per week.
Dietary intervention: Subjects in the control group will follow the their current dietary protocol (Standard American Diet-SAD).</description>
          </group>
        </group_list>
        <measure>
          <title>HgA1c</title>
          <description>Assessment of changes in HgA1c (Hemoglobin A1c) over time.</description>
          <units>percentage of glycated hemoglobin</units>
          <param>Geometric Least Squares Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
                <count group_id="O2" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.19" lower_limit="5.11" upper_limit="5.28"/>
                    <measurement group_id="O2" value="5.82" lower_limit="5.73" upper_limit="5.91"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <method>Regression, Linear</method>
            <param_type>Estimate</param_type>
            <param_value>0.87</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.01</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.85</ci_lower_limit>
            <ci_upper_limit>0.88</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Weight</title>
        <description>Assessment of changes in weight over time as measured in pounds.</description>
        <time_frame>12-weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Experimental Group</title>
            <description>Dietary interventions for subjects in the experimental group include clinically regulated meal plans designed to facilitate prolonged benign dietary ketosis (BDK) in order to regulate glucose with restored insulin sensitivity focused at reversing the impaired capacity to switch between fat and carbohydrate oxidation. Subjects will consume 3 meals per day with the following approximate macronutrient breakdown per meal: 65% fat, 25% protein, 10% carbohydrate.
Both groups will play the Advanced PEAK brain training games on iPhone, iPad or Android devices for 75 minutes per week.
Dietary intervention: Subjects in the experimental group will receive clinically regulated meal plans designed to facilitate prolonged benign dietary ketosis (BDK) in order to regulate glucose with restored insulin sensitivity focused at reversing the impaired capacity to switch between fat and carbohydrate oxidation.</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>Dietary interventions for subjects in the control group include the subjects' current dietary protocol (Standard American Diet-SAD). Subjects will consume 4-6 small meals per day with the following approximate macronutrient breakdown per meal: 50% carbohydrate, 35% protein, 15% fat.
Both groups will play the Advanced PEAK brain training games on iPhone, iPad or Android devices for 75 minutes per week.
Dietary intervention: Subjects in the control group will follow the their current dietary protocol (Standard American Diet-SAD).</description>
          </group>
        </group_list>
        <measure>
          <title>Weight</title>
          <description>Assessment of changes in weight over time as measured in pounds.</description>
          <units>pounds</units>
          <param>Geometric Least Squares Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
                <count group_id="O2" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="200.23" lower_limit="189.46" upper_limit="211.62"/>
                    <measurement group_id="O2" value="210.60" lower_limit="199.49" upper_limit="222.32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <method>Regression, Linear</method>
            <param_type>Estimate</param_type>
            <param_value>0.87</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.01</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.85</ci_lower_limit>
            <ci_upper_limit>0.88</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Body Fat Mass (BFM)</title>
        <description>Assessment of changes in body fat mass over time as measured in pounds.</description>
        <time_frame>12-weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Experimental Group</title>
            <description>Dietary interventions for subjects in the experimental group include clinically regulated meal plans designed to facilitate prolonged benign dietary ketosis (BDK) in order to regulate glucose with restored insulin sensitivity focused at reversing the impaired capacity to switch between fat and carbohydrate oxidation. Subjects will consume 3 meals per day with the following approximate macronutrient breakdown per meal: 65% fat, 25% protein, 10% carbohydrate.
Both groups will play the Advanced PEAK brain training games on iPhone, iPad or Android devices for 75 minutes per week.
Dietary intervention: Subjects in the experimental group will receive clinically regulated meal plans designed to facilitate prolonged benign dietary ketosis (BDK) in order to regulate glucose with restored insulin sensitivity focused at reversing the impaired capacity to switch between fat and carbohydrate oxidation.</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>Dietary interventions for subjects in the control group include the subjects' current dietary protocol (Standard American Diet-SAD). Subjects will consume 4-6 small meals per day with the following approximate macronutrient breakdown per meal: 50% carbohydrate, 35% protein, 15% fat.
Both groups will play the Advanced PEAK brain training games on iPhone, iPad or Android devices for 75 minutes per week.
Dietary intervention: Subjects in the control group will follow the their current dietary protocol (Standard American Diet-SAD).</description>
          </group>
        </group_list>
        <measure>
          <title>Body Fat Mass (BFM)</title>
          <description>Assessment of changes in body fat mass over time as measured in pounds.</description>
          <units>pounds</units>
          <param>Geometric Least Squares Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
                <count group_id="O2" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="67.95" lower_limit="62.21" upper_limit="74.21"/>
                    <measurement group_id="O2" value="79.35" lower_limit="72.78" upper_limit="86.52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <method>Regression, Linear</method>
            <param_type>Estimate</param_type>
            <param_value>0.75</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.02</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.71</ci_lower_limit>
            <ci_upper_limit>0.80</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>VLDL</title>
        <description>Assessment of changes in VLDL (very low density lipoprotein carrier) over time. Ranges: &lt; 5-40 mg/dL</description>
        <time_frame>12-weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Experimental Group</title>
            <description>Dietary interventions for subjects in the experimental group include clinically regulated meal plans designed to facilitate prolonged benign dietary ketosis (BDK) in order to regulate glucose with restored insulin sensitivity focused at reversing the impaired capacity to switch between fat and carbohydrate oxidation. Subjects will consume 3 meals per day with the following approximate macronutrient breakdown per meal: 65% fat, 25% protein, 10% carbohydrate.
Both groups will play the Advanced PEAK brain training games on iPhone, iPad or Android devices for 75 minutes per week.
Dietary intervention: Subjects in the experimental group will receive clinically regulated meal plans designed to facilitate prolonged benign dietary ketosis (BDK) in order to regulate glucose with restored insulin sensitivity focused at reversing the impaired capacity to switch between fat and carbohydrate oxidation.</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>Dietary interventions for subjects in the control group include the subjects' current dietary protocol (Standard American Diet-SAD). Subjects will consume 4-6 small meals per day with the following approximate macronutrient breakdown per meal: 50% carbohydrate, 35% protein, 15% fat.
Both groups will play the Advanced PEAK brain training games on iPhone, iPad or Android devices for 75 minutes per week.
Dietary intervention: Subjects in the control group will follow the their current dietary protocol (Standard American Diet-SAD).</description>
          </group>
        </group_list>
        <measure>
          <title>VLDL</title>
          <description>Assessment of changes in VLDL (very low density lipoprotein carrier) over time. Ranges: &lt; 5-40 mg/dL</description>
          <units>mg/dL</units>
          <param>Geometric Least Squares Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
                <count group_id="O2" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17.45" lower_limit="15.32" upper_limit="19.87"/>
                    <measurement group_id="O2" value="26.35" lower_limit="23.19" upper_limit="29.93"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <method>Regression, Linear</method>
            <param_type>Estimate</param_type>
            <param_value>0.51</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.02</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.47</ci_lower_limit>
            <ci_upper_limit>0.56</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>SAM/SAH Ratio (S-adenosylmethionine/S-adenosylhomocysteine)</title>
        <description>Assessment of changes in SAM/SAH (S-adenosylmethionine/S-adenosylhomocysteine) ratio Range: &gt;4.0</description>
        <time_frame>12-weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Experimental Group</title>
            <description>Dietary interventions for subjects in the experimental group include clinically regulated meal plans designed to facilitate prolonged benign dietary ketosis (BDK) in order to regulate glucose with restored insulin sensitivity focused at reversing the impaired capacity to switch between fat and carbohydrate oxidation. Subjects will consume 3 meals per day with the following approximate macronutrient breakdown per meal: 65% fat, 25% protein, 10% carbohydrate.
Both groups will play the Advanced PEAK brain training games on iPhone, iPad or Android devices for 75 minutes per week.
Dietary intervention: Subjects in the experimental group will receive clinically regulated meal plans designed to facilitate prolonged benign dietary ketosis (BDK) in order to regulate glucose with restored insulin sensitivity focused at reversing the impaired capacity to switch between fat and carbohydrate oxidation.</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>Dietary interventions for subjects in the control group include the subjects' current dietary protocol (Standard American Diet-SAD). Subjects will consume 4-6 small meals per day with the following approximate macronutrient breakdown per meal: 50% carbohydrate, 35% protein, 15% fat.
Both groups will play the Advanced PEAK brain training games on iPhone, iPad or Android devices for 75 minutes per week.
Dietary intervention: Subjects in the control group will follow the their current dietary protocol (Standard American Diet-SAD).</description>
          </group>
        </group_list>
        <measure>
          <title>SAM/SAH Ratio (S-adenosylmethionine/S-adenosylhomocysteine)</title>
          <description>Assessment of changes in SAM/SAH (S-adenosylmethionine/S-adenosylhomocysteine) ratio Range: &gt;4.0</description>
          <units>ratio</units>
          <param>Geometric Least Squares Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
                <count group_id="O2" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4.938" lower_limit="4.538" upper_limit="5.372"/>
                    <measurement group_id="O2" value="4.491" lower_limit="4.119" upper_limit="4.896"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <method>Regression, Linear</method>
            <param_type>Estimate</param_type>
            <param_value>1.130</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.013</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.104</ci_lower_limit>
            <ci_upper_limit>1.156</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>SAM (S-adenosylmethionine)</title>
        <description>Assessment of changes in SAM (S-adenosylmethionine)</description>
        <time_frame>12-weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Experimental Group</title>
            <description>Dietary interventions for subjects in the experimental group include clinically regulated meal plans designed to facilitate prolonged benign dietary ketosis (BDK) in order to regulate glucose with restored insulin sensitivity focused at reversing the impaired capacity to switch between fat and carbohydrate oxidation. Subjects will consume 3 meals per day with the following approximate macronutrient breakdown per meal: 65% fat, 25% protein, 10% carbohydrate.
Both groups will play the Advanced PEAK brain training games on iPhone, iPad or Android devices for 75 minutes per week.
Dietary intervention: Subjects in the experimental group will receive clinically regulated meal plans designed to facilitate prolonged benign dietary ketosis (BDK) in order to regulate glucose with restored insulin sensitivity focused at reversing the impaired capacity to switch between fat and carbohydrate oxidation.</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>Dietary interventions for subjects in the control group include the subjects' current dietary protocol (Standard American Diet-SAD). Subjects will consume 4-6 small meals per day with the following approximate macronutrient breakdown per meal: 50% carbohydrate, 35% protein, 15% fat.
Both groups will play the Advanced PEAK brain training games on iPhone, iPad or Android devices for 75 minutes per week.
Dietary intervention: Subjects in the control group will follow the their current dietary protocol (Standard American Diet-SAD).</description>
          </group>
        </group_list>
        <measure>
          <title>SAM (S-adenosylmethionine)</title>
          <description>Assessment of changes in SAM (S-adenosylmethionine)</description>
          <units>nmol/L</units>
          <param>Geometric Least Squares Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
                <count group_id="O2" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="89.784" lower_limit="84.767" upper_limit="95.099"/>
                    <measurement group_id="O2" value="88.177" lower_limit="83.131" upper_limit="93.529"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <method>Regression, Linear</method>
            <param_type>Estimate</param_type>
            <param_value>1.037</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.025</ci_lower_limit>
            <ci_upper_limit>1.049</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>SAH (S-adenosylhomocysteine)</title>
        <description>Assessment of changes in SAH (S-adenosylhomocysteine) Range: 10-22 nmol/L</description>
        <time_frame>12-weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Experimental Group</title>
            <description>Dietary interventions for subjects in the experimental group include clinically regulated meal plans designed to facilitate prolonged benign dietary ketosis (BDK) in order to regulate glucose with restored insulin sensitivity focused at reversing the impaired capacity to switch between fat and carbohydrate oxidation. Subjects will consume 3 meals per day with the following approximate macronutrient breakdown per meal: 65% fat, 25% protein, 10% carbohydrate.
Both groups will play the Advanced PEAK brain training games on iPhone, iPad or Android devices for 75 minutes per week.
Dietary intervention: Subjects in the experimental group will receive clinically regulated meal plans designed to facilitate prolonged benign dietary ketosis (BDK) in order to regulate glucose with restored insulin sensitivity focused at reversing the impaired capacity to switch between fat and carbohydrate oxidation.</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>Dietary interventions for subjects in the control group include the subjects' current dietary protocol (Standard American Diet-SAD). Subjects will consume 4-6 small meals per day with the following approximate macronutrient breakdown per meal: 50% carbohydrate, 35% protein, 15% fat.
Both groups will play the Advanced PEAK brain training games on iPhone, iPad or Android devices for 75 minutes per week.
Dietary intervention: Subjects in the control group will follow the their current dietary protocol (Standard American Diet-SAD).</description>
          </group>
        </group_list>
        <measure>
          <title>SAH (S-adenosylhomocysteine)</title>
          <description>Assessment of changes in SAH (S-adenosylhomocysteine) Range: 10-22 nmol/L</description>
          <units>nmol/L</units>
          <param>Geometric Least Squares Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
                <count group_id="O2" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.257" lower_limit="17.685" upper_limit="18.847"/>
                    <measurement group_id="O2" value="19.566" lower_limit="18.938" upper_limit="20.214"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <method>Regression, Linear</method>
            <param_type>Estimate</param_type>
            <param_value>0.93</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.008</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.91</ci_lower_limit>
            <ci_upper_limit>0.94</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Adenosine</title>
        <description>Assessment of changes in Adenosine Range: 20-80 nmol/L</description>
        <time_frame>12-weeks</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Experimental Group</title>
            <description>Dietary interventions for subjects in the experimental group include clinically regulated meal plans designed to facilitate prolonged benign dietary ketosis (BDK) in order to regulate glucose with restored insulin sensitivity focused at reversing the impaired capacity to switch between fat and carbohydrate oxidation. Subjects will consume 3 meals per day with the following approximate macronutrient breakdown per meal: 65% fat, 25% protein, 10% carbohydrate.
Both groups will play the Advanced PEAK brain training games on iPhone, iPad or Android devices for 75 minutes per week.
Dietary intervention: Subjects in the experimental group will receive clinically regulated meal plans designed to facilitate prolonged benign dietary ketosis (BDK) in order to regulate glucose with restored insulin sensitivity focused at reversing the impaired capacity to switch between fat and carbohydrate oxidation.</description>
          </group>
          <group group_id="O2">
            <title>Control Group</title>
            <description>Dietary interventions for subjects in the control group include the subjects' current dietary protocol (Standard American Diet-SAD). Subjects will consume 4-6 small meals per day with the following approximate macronutrient breakdown per meal: 50% carbohydrate, 35% protein, 15% fat.
Both groups will play the Advanced PEAK brain training games on iPhone, iPad or Android devices for 75 minutes per week.
Dietary intervention: Subjects in the control group will follow the their current dietary protocol (Standard American Diet-SAD).</description>
          </group>
        </group_list>
        <measure>
          <title>Adenosine</title>
          <description>Assessment of changes in Adenosine Range: 20-80 nmol/L</description>
          <units>nmol/L</units>
          <param>Geometric Least Squares Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="48"/>
                <count group_id="O2" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23.363" lower_limit="22.413" upper_limit="24.352"/>
                    <measurement group_id="O2" value="21.475" lower_limit="20.581" upper_limit="22.407"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Other</non_inferiority_type>
            <p_value>&lt;0.0001</p_value>
            <method>Regression, Linear</method>
            <param_type>Estimate</param_type>
            <param_value>1.122</param_value>
            <dispersion_type>Standard Error of the Mean</dispersion_type>
            <dispersion_value>0.014</dispersion_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.096</ci_lower_limit>
            <ci_upper_limit>1.149</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>12-weeks</time_frame>
      <desc>Study protocol/procedures non-invasive</desc>
      <group_list>
        <group group_id="E1">
          <title>Experimental Group</title>
          <description>Dietary interventions for subjects in the experimental group include clinically regulated meal plans designed to facilitate prolonged benign dietary ketosis (BDK) in order to regulate glucose with restored insulin sensitivity focused at reversing the impaired capacity to switch between fat and carbohydrate oxidation. Subjects will consume 3 meals per day with the following approximate macronutrient breakdown per meal: 65% fat, 25% protein, 10% carbohydrate.
Both groups will play the Advanced PEAK brain training games on iPhone, iPad or Android devices for 75 minutes per week.
Dietary intervention: Subjects in the experimental group will receive clinically regulated meal plans designed to facilitate prolonged benign dietary ketosis (BDK) in order to regulate glucose with restored insulin sensitivity focused at reversing the impaired capacity to switch between fat and carbohydrate oxidation.</description>
        </group>
        <group group_id="E2">
          <title>Control Group</title>
          <description>Dietary interventions for subjects in the control group include the subjects' current dietary protocol (Standard American Diet-SAD). Subjects will consume 4-6 small meals per day with the following approximate macronutrient breakdown per meal: 50% carbohydrate, 35% protein, 15% fat.
Both groups will play the Advanced PEAK brain training games on iPhone, iPad or Android devices for 75 minutes per week.
Subjects in the control group will follow the their current dietary protocol (Standard American Diet-SAD).</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="50"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="48"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>No limitations or caveats</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Kelly J. Gibas</name_or_title>
      <organization>Bristlecone Health, Inc.</organization>
      <phone>763-913-4600</phone>
      <email>kelly-gibas@bethel.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

